IJ
ProgramAn AI Foundation Toxicology Model and Framework to Support Waiving a Second Species in Drug Safety Studies
Funds development of an AI toxicology model that lets drug developers waive costly second-species animal safety testing.
Innovative Health Initiative Joint Undertaking (IHI JU)CanadaSwitzerlandUnited KingdomSouth KoreaGrant
About
A consortium of pharmaceutical companies, regulators, academic institutions, SMEs and patient groups consolidates existing toxicology datasets, builds and validates the AI model, and pursues regulatory engagement with bodies such as the EMA and FDA. This is a two-stage Research and Innovation Action: a 20-page short proposal by the first deadline, then a 50-page full proposal by the second, funded…
AIMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.